Allergan, Inc.

Robert S Jordan

Chetan Pujara

Anuradha V Gore

Kevin Krock

Robert T Lyons

Richard S Graham

Kevin S Warner

Ajay P Parashar

Sukhon Likitlersuang

Mu-Lan Lee

Chetan P Pujara

The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.

Artificial tears and therapeutic uses

The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma.

Ophthalmic formulations containing substituted gamma lactams and methods for use thereof

Citric acid and conjugate bases thereof are useful for stabilizing stabilized chlorine dioxide in the presence of therapeutically active agents and excipients in a composition. Ophthalmic compositions and methods related thereto are also disclosed herein.

Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative

The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.

Stabilized compositions comprising a therapeutically active agent, and an oxidizing preservative

Growing community of inventors

Trabuco Canyon, CA, United States of America

Robert S Jordan